BC
The company develops small molecule drugs targeting myeloma, hypercholesterolemia, and tumors to provide effective treatment options for patients with chronic diseases. By focusing on specific disease mechanisms, the company aims to enhance therapeutic outcomes and improve patient quality of life.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops small molecule drugs targeting myeloma, hypercholesterolemia, and tumors to provide effective treatment options for patients with chronic diseases. By focusing on specific disease mechanisms, the company aims to enhance therapeutic outcomes and improve patient quality of life.